WST WEST PHARMACEUTICAL SERVICES INC

BEARISH Impact: 7/10 8-K
Horizon weeks Filed May 11, 2026 Processed 1mo ago SEC 0000105770-26-000068
8-K Item 1.05: Material cybersecurity incident (mandatory SEC disclosure)
Latest settled — T+5d
WST ▼ -2.38% at T+5d
SHORT call ✓ call won +2.38% · α vs SPY +2.46% · entry $311.82 → $304.41
Next anchor: T+20d due 4d ago
Currently $328.82 · -5.45% from $311.82 entry (call sign-flipped)
Entry anchored
May 11, 2026
via day open
T+1d
+0.08%
call -0.08% · α +0.46%
$312.07
settled 5w ago
T+5d
-2.38%
call +2.38% · α +2.46%
$304.41
settled 26d ago
T+20d
call — · α —
due 4d ago
T+60d
call — · α —
in 8w

Price Chart

Loading chart...

Executive Summary

West Pharmaceutical (WST) disclosed a material cybersecurity attack on May 7, 2026, with data exfiltration and system encryption discovered on May 4. Operations were temporarily disrupted globally; core systems and critical processes at some sites have been restored, but full recovery timeline is unknown. Financial impact is not yet determinable.

Actionable Insight

Monitor for further disclosures on restoration timeline, data breach scope, and financial impact estimates. Expect potential earnings guidance withdrawal or reduction. Watch for class action lawsuits or regulatory investigations.

Key Facts

  • Material cybersecurity attack determined on May 7, 2026; intrusion detected May 4.
  • Data exfiltrated and systems encrypted; proactive shutdown and isolation of systems.
  • Global business operations temporarily disrupted; core enterprise systems restored, shipping/receiving/manufacturing restarted at some sites.
  • Investigation ongoing with Palo Alto Networks Unit 42 engaged.
  • Material financial impact not yet determined.

Financial Impact

Not yet quantified; potential remediation costs, business interruption losses, and regulatory penalties.

revenueoperatingIncomecashFlow

Risk Factors

  • Extended operational disruption could impact Q2 2026 revenue and margins.
  • Remediation costs and potential regulatory fines or litigation expenses.
  • Customer and partner trust erosion may affect future contracts.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
83% bullish (23 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000105770-26-000068
Document: westcompanyalertswebsite.htm0000105770-26-000068
Document: 0000105770-26-000068-index-headers.html0000105770-26-000068
Document: 0000105770-26-000068-index.html0000105770-26-000068
Document: 0000105770-26-000068.txt0000105770-26-000068
9 reports for WST
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for WST — sortable, filterable
Type Now
May 11, 2026
4w ago
8-K
BEARISH ★ 7/10
$311.82 $304.41▲ +2.38%▲ +2.46%$328.82 (−5.45%)
Apr 27, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $299.68▼ −0.42%▼ −0.82%$328.82 (+9.27%)
Apr 27, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $299.68▼ −0.42%▼ −0.82%$328.82 (+9.27%)
Apr 27, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $299.68▼ −0.42%▼ −0.82%$328.82 (+9.27%)
Apr 27, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $299.68▼ −0.42%▼ −0.82%$328.82 (+9.27%)
Apr 27, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $299.68▼ −0.42%▼ −0.82%$328.82 (+9.27%)
Apr 27, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $299.68▼ −0.42%▼ −0.82%$328.82 (+9.27%)
Apr 23, 2026
7w ago
8-K
BULLISH ★ 8/10
$307.95 $295.36▼ −4.09%▼ −5.57%$328.82 (+6.78%)
Mar 12, 2026
13w ago
DEFA14A
NEUTRAL ★ 2/10
$230.82 $240.05▲ +4.00%▲ +4.98%$328.82 (+42.45%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (48h 14m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access